Faulkner Hospital

Boston, Massachusetts 02215

0 studies enrolling now · 18 studies all time

What they study most

Arthroplasties, Replacement, Breast Cancer, Breast Neoplasms, DCIS, Esophageal Cancer, GE Junction Cancer, Gastric Cancer, Hysterectomy, Invasive Breast Carcinoma, Neoplasms, Nutrition, Osteoporosis

Studies at this site

• Weight Loss Before Total Joint Arthroplasty Using A Remote Dietitian and Mobile App — Completed
• Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer — Completed
• Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer — Stopped early
• RCT Superior Hypogastric Block During LH — Completed
• Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer — Completed
• AirXpanders AeroForm Tissue Expander System for Breast Reconstruction — Completed
• Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction — Completed
• Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer — Completed
• Patient Controlled Tissue Expansion for Breast Reconstruction — Completed
• Application Time of Plaster-of-Paris Splint Packs Compared to Bulk Supplies Following Standard Orthopaedic Procedure — Completed
• Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer — Completed
• Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy — Stopped early
• Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer — Completed
• Capecitabine in Women With Operable Breast Cancer — Stopped early
• Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer — Completed
• Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer — Completed
• Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer — Completed
• Educational Interventions for Patients With DCIS — Completed